Report cover image

Benelux Point-Of-Care-Testing (POCT) Market

Publisher Data Bridge Market Research
Published May 01, 2025
Length 350 Pages
SKU # DAABD20406947

Description

The Benelux Point-of-Care-Testing (POCT) market is expected to reach USD 1,819.37 million by 2032 from USD 882.98 million in 2024, growing at a substantial CAGR of 9.5% in the forecast period of 2025 to 2032.

Market Segmentation:

Benelux Point-Of-Care-Testing (POCT) Market, By Product Type (Glucose Monitoring Products, Infectious Disease Testing Products, Cardiometabolic Monitoring Products, Pregnancy and Fertility Testing Products, Hematology Testing Products ,Coagulation Monitoring Products, Drugs-Of-Abuse (DOA) Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Tumor/Cancer Marker Testing Products, Fecal Occult Testing Products, and Others), Platform (Lateral Flow Assays/Immunochromatography Tests, Immunoassays, Dipsticks, Molecular Diagnostics, Clinical Chemistry Assays, Microfluidics, Hematology, and Others), Application (Blood Glucose, Infectious Diseases, Vital Sign Monitoring, Cardiac Monitoring, Coagulation, Haematology, Non- Invasive SpO2 Monitoring, Blood Transfusion, Non- Invasive PCO2 Monitoring, Whole Blood Analysis, and Others), Prescription Mode (Prescription-Based Testing and Over The Counter Testing), End User (Hospitals, Home Care, Clinics, Laboratories, Diagnostic Centers, Pathology Labs, Ambulatory Surgery Centers, Elderly Care Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, Online Sales, and Others), Country (Netherlands, Belgium, and Luxembourg) - Industry Trends & Forecast To 2032

Overview of the Benelux Point-of-Care-Testing (POCT) Market are:

Driver
• Rising Use of POC Testing in Healthcare Facilities

Restraint
• Data Security and Privacy Concerns

Opportunity
• Rising Awareness and Advocacy for Point-Of-Care Testing

Market Players:

The key market players for Benelux Point-of-Care-Testing (POCT) market are listed below:
• F. Hoffmann-La Roche Ltd
• Danaher Corporation
• Siemens Healthineers AG
• Bio-Rad Laboratories, Inc.
• BIOMÉRIEUX
• BD (Becton, Dickinson and Company)
• QuidelOrtho Corporation
• Hologic, Inc.
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Werfen
• QIAGEN
• Sysmex Europe SE
• EKF Diagnostics Holdings plc.
• SEKISUI Diagnostics
• MERIDIAN BIOSCIENCE
• binx health, inc.
• Trinity Biotech
• Sienco, Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

Table of Contents

350 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The Gsa And Benelux Point-of-care-testing (Poct) Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Years Considered For The Study
2.3 Currency And Pricing
2.4 Dbmr Tripod Data Validation Model
2.5 Multivariate Modelling
2.6 Product Type Lifeline Curve
2.7 Primary Interviews With Key Opinion Leaders
2.8 Dbmr Market Position Grid
2.9 Market End User Coverage Grid
2.10 Secondary Sources
2.11 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestal Analysis
4.2 Porters Five Forces Analysis
4.3 Micro And Macro Economic Factors
4.4 Penetration And Growth Prospect Mapping
4.5 Key Pricing Strategies
4.6 Cost Analysis Breakdown
4.7 Opportunity Map Analysis
4.8 Value Chain Analysis
4.9 Healthcare Economy
4.10 Tariffs
4.10.1 Definition And Importance Of Tariffs In The Healthcare Sector
4.10.2 Global Vs. Regional Tariff Structures
4.10.3 Impact Of Tariffs On Healthcare Costs And Accessibility
4.10.4 Tariff Regulations In Key Markets
4.10.4.1 Medicare/Medicaid Tariff Policies
4.10.4.2 Cms Pricing Models
4.10.4.3 Others
4.10.5 Tariffs On Medical Devices & Equipment
4.10.5.1 Import/Export Duties On Medical Equipment
4.10.5.2 Impact On Pricing And Availability Of High-end Medical Technology
4.10.5.3 Case Studies Of Tariff Changes Affecting The Industry
4.10.6 Cost Burden On Hospitals And Healthcare Facilities
4.10.7 Tariff Exemptions And Incentives
4.10.8 Duty-free Imports For Essential Medicines And Vaccines
4.10.9 16.9 Impact Of Trade Wars On The Healthcare Supply Chain
4.10.10 Role Of Free Trade Agreements (Ftas) In Reducing Tariffs
5 Customization
5.1 Leading Digital Health Platforms In Each Country –
5.2 Poct Data Integration Use Cases –
5.3 Informatics Platforms & Telemedicine Integration:
6 Regulatory
6.1 Regulatory Gsa
6.2 Regulatory Benelux
7 Market Overview
7.1 Drivers
7.1.1 Rising Use Of Poc Testing In Healthcare Facilities
7.1.2 Rising Incidence Of Substance Abuse
7.1.3 Increased Adoption Of Telemedicine
7.1.4 Advancements Technologies Enhancing Poc Testing With Biosensors And Mobile Integration
7.2 Restraints
7.2.1 Data Security And Privacy Concerns
7.2.2 Accuracy Limitations And Technical Barriers
7.3 Opportunities
7.3.1 Rising Awareness And Advocacy For Point-of-care Testing
7.3.2 Strategic Initiation And Decision Taken By The Market Players
7.3.3 Expanding Product Range For Point-of-care Testing
7.4 Challenges
7.4.1 Limited Awareness And Acceptance Of Point-of-care (Poc) Testing
7.4.2 Impact Of High Maintenance Costs Threaten Point-of-care Testing (Poct) Sustainability In Low-resource Settings
8 Gsa Point-of-care Testing (Poct) Market, By Product Type
8.1 Overview
8.2 Glucose Monitoring Products
8.2.1 Strips
8.2.2 Meters
8.2.3 Lancets And Lancing Devices
8.3 Infectious Disease Testing Products
8.3.1 Covid-19
8.3.2 Hiv Testing Products
8.3.2.1 Testing Reagents
8.3.2.2 Testing Equipment
8.3.3 Respiratory Infection Testing Products
8.3.4 Sexually Transmitted Diseases (Std) Testing
8.3.4.1 Naat-based Systems
8.3.4.2 Non–naat-based Systems
8.3.5 Hepatitis C Testing Products
8.3.5.1 Hcv Antibody Tests
8.3.5.2 Hcv Viral Load Tests
8.3.6 Influenza Testing Products
8.3.6.1 Traditional Diagnostic Test
8.3.6.1.1 Rapid Influenza Diagnostic Test (Ridt)
8.3.6.1.2 Direct Fluorescent Antibody Test (Dfat)
8.3.6.1.3 Viral Culture
8.3.6.1.4 Serological Assay
8.3.6.2 Molecular Diagnostic Assay
8.3.6.2.1 Rt-pcr
8.3.6.2.2 Loop-mediated Isothermal Amplification-based Assay (Lamp)
8.3.6.2.3 Nucleic Acid Sequence-based Amplification Test (Nasbat)
8.3.6.2.4 Simple Amplification-based Assay (Samba)
8.3.7 Healthcare Associated Infection (Hai) Testing
8.3.8 Tropical Disease Testing Products
8.3.9 Other Infectious Disease Testing Products
8.4 Cardiometabolic Monitoring Products
8.4.1 Cardiac Marker Testing Products
8.4.1.1 Hstnl
8.4.1.2 Bnp
8.4.1.3 D-dimer
8.4.1.4 Ck-mb
8.4.1.5 Myoglobin
8.4.2 Blood Gas/Electrolyte Testing Products
8.4.3 Blood Gas/Electrolyte Testing Consumables
8.4.3.1 Cartridges
8.4.3.2 Reagents
8.4.4 Blood Gas/Electrolyte Testing Instruments
8.4.4.1 Portable
8.4.4.1.1 Combined Analyzers
8.4.4.1.2 Blood Gas Analyzers
8.4.4.1.3 Electrolyte Analyzers
8.4.4.2 Benchtop
8.4.4.2.1 Combined Analyzers
8.4.4.2.2 Blood Gas Analyzers
8.4.4.2.3 Electrolyte Analyzers
8.4.5 Hba1c Testing Products
8.4.5.1 Hba1c Testing Instruments
8.4.5.2 Hba1c Testing Consumables
8.4.6 Poc Analyzer
8.4.7 Ecg Device
8.4.7.1 Resting Ecg Devices
8.4.7.2 Stress Ecg Devices
8.4.7.3 Holter Monitors
8.5 Pregnancy And Fertility Testing Products
8.5.1 Pregnancy Testing Products
8.5.1.1 Strips/ Dip Sticks And Cards
8.5.1.2 Mid Stream Devices
8.5.1.3 Cassettes
8.5.1.4 Digital Devices
8.5.1.5 Line-indicator Devices
8.5.2 Fertility Testing Products
8.5.2.1 Luteinizing Hormone (Lh) Urine Test
8.5.2.2 Fsh Test
8.5.2.3 Others
8.6 Haematology Testing Products
8.7 Coagulation Monitoring Products
8.7.1 Anticoagulation Monitoring Devices
8.7.1.1 Prothrombin Time/International Normalized Ratio (Pt-inr) Testing Devices
8.7.1.2 Activated Clotting Time (Act)
8.7.1.3 Activated Partial Thromboplastin Time (Appt)
8.7.2 Platelet Function Monitoring Devices
8.7.3 Viscoelastic Coagulation Monitoring Devices
8.7.3.1 Rotational Thromboelastometry (Rotem)
8.7.3.2 Thromboelastography (Teg)
8.8 Drug-of-abuse (Doa) Testing Products
8.8.1 Doa Analysers
8.8.1.1 Immunoassays
8.8.1.2 Chromatographic Devices
8.8.1.3 Breath Analysers
8.8.2 Rapid Testing Devices
8.8.2.1 Urine Testing Devices
8.8.2.2 Oral Fluid Testing Devices
8.8.2.3 Others
8.9 Urinalysis Testing Products
8.9.1 Poc Urine Strip Self-testing
8.9.2 Poc Urine Test Strip Professional Testing
8.10 Cholesterol Testing Products
8.10.1 Testing Kits
8.10.2 Instruments
8.10.2.1 Table-top Analyzers
8.10.2.2 Hand-held Analyzers
8.11 Tumor/Cancer Marker Testing Products
8.12 Fecal Occult Testing Products
8.12.1 Guaiac Fob Stool Test
8.12.2 Lateral Flow Immuno-fob Test
8.12.3 Immuno-fob Agglutination Test
8.12.4 Immuno-fob Elisa Test
8.13 Others
9 Gsa Point-of-care Testing (Poct) Market, By Prescription Mode
9.1 Overview
9.2 Otc Testing
9.3 Prescription-based Testing
10 Gsa Point-of-care Testing (Poct) Market, By Platform
10.1 Overview
10.2 Lateral Flow Assays/Immunochromatography Tests
10.3 Immunoassays
10.4 Dipsticks
10.5 Molecular Diagnostics
10.6 Clinical Chemistry Assays
10.7 Microfluidics
10.8 Hematology
10.9 Others
11 Gsa Point-of-care-testing (Poct) Market, By Application
11.1 Overview
11.2 Blood Glucose
11.3 Infectious Diseases
11.3.1 Covid-19 Testing
11.3.2 Hiv Testing
11.3.3 Hepatitis C Testing
11.3.4 Influenza Testing
11.3.5 Tuberculosis Testing
11.3.6 Others
11.4 Vital Sign Monitoring
11.5 Cardiac Monitoring
11.6 Coagulation
11.7 Haematology
11.8 Non- Invasive Spo2 Monitoring
11.9 Blood Transfusion
11.10 Non- Invasive Pco2 Monitoring
11.11 Whole Blood Analysis
11.12 Others
12 Gsa Point-of-care Testing (Poct) Market, By End User
12.1 Overview
12.2 Hospitals
12.2.1 Private
12.2.1.1 Tier 1
12.2.1.2 Tier 2
12.2.1.3 Tier 3
12.2.2 Public
12.3 Home Care
12.4 Clinics
12.5 Laboratories
12.6 Diagnostic Centers
12.7 Pathology Labs
12.8 Ambulatory Surgery Centers
12.9 Elderly Care Centers
12.10 Others
13 Gsa Point-of-care-testing (Poct) Market, By Distribution Channel
13.1 Overview
13.2 Direct Tender
13.3 Retail Sales
13.4 Online Sales
13.5 Others
14 Benelux Point-of-care Testing (Poct) Market, By Product Type
14.1 Overview
14.2 Glucose Monitoring Products
14.2.1 Strips
14.2.2 Meters
14.2.3 Lancets And Lancing Devices
14.3 Infectious Disease Testing Products
14.3.1 Covid-19
14.3.2 Hiv Testing Products
14.3.2.1 Testing Reagents
14.3.2.2 Testing Equipment
14.3.3 Respiratory Infection Testing Products
14.3.4 Sexually Transmitted Diseases (Std) Testing
14.3.5 Naat-based Systems
14.3.6 Non–naat-based Systems
14.3.7 Hepatitis C Testing Products
14.3.7.1 Hcv Antibody Tests
14.3.7.2 Hcv Viral Load Tests
14.3.8 Influenza Testing Products
14.3.8.1 Traditional Diagnostic Test
14.3.8.1.1 Rapid Influenza Diagnostic Test (Ridt)
14.3.8.1.2 Direct Fluorescent Antibody Test (Dfat)
14.3.8.1.3 Viral Culture
14.3.8.1.4 Serological Assay
14.3.8.2 Molecular Diagnostic Assay
14.3.8.2.1 Rt-pcr
14.3.8.2.2 Loop-mediated Isothermal Amplification-based Assay (Lamp)
14.3.8.2.3 Nucleic Acid Sequence-based Amplification Test (Nasbat)
14.3.8.2.4 Simple Amplification-based Assay (Samba)
14.3.9 Healthcare Associated Infection (Hai) Testing
14.3.10 Tropical Disease Testing Products
14.3.11 Other Infectious Disease Testing Products
14.4 Cardiometabolic Monitoring Products
14.4.1 Cardiac Marker Testing Products
14.4.1.1 Hstnl
14.4.1.2 Bnp
14.4.1.3 D-dimer
14.4.1.4 Ck-mb
14.4.1.5 Myoglobin
14.4.2 Blood Gas/Electrolyte Testing Products
14.4.3 Blood Gas/Electrolyte Testing Consumables
14.4.3.1 Cartridges
14.4.3.2 Reagents
14.4.4 Blood Gas/Electrolyte Testing Instruments
14.4.5 Portable
14.4.5.1 Combined Analyzers
14.4.5.2 Blood Gas Analyzers
14.4.5.3 Electrolyte Analyzers
14.4.6 Benchtop
14.4.6.1 Combined Analyzers
14.4.6.2 Blood Gas Analyzers
14.4.6.3 Electrolyte Analyzers
14.4.7 Hba1c Testing Products
14.4.7.1 Hba1c Testing Instruments
14.4.7.2 Hba1c Testing Consumables
14.4.8 Poc Analyzer
14.4.9 Ecg Device
14.4.9.1 Resting Ecg Devices
14.4.9.2 Stress Ecg Devices
14.4.9.3 Holter Monitors
14.5 Pregnancy And Fertility Testing Products
14.5.1 Pregnancy Testing Products
14.5.1.1 Strips/ Dip Sticks And Cards
14.5.1.2 Mid Stream Devices
14.5.1.3 Cassettes
14.5.1.4 Digital Devices
14.5.1.5 Line-indicator Devices
14.5.2 Fertility Testing Products
14.5.2.1 Luteinizing Hormone (Lh) Urine Test
14.5.2.2 Fsh Test
14.5.2.3 Others
14.6 Haematology Testing Products
14.7 Coagulation Monitoring Products
14.8 Anticoagulation Monitoring Devices
14.8.1 Prothrombin Time/International Normalized Ratio (Pt-inr) Testing Devices
14.8.2 Activated Clotting Time (Act)
14.8.3 Activated Partial Thromboplastin Time (Appt)
14.8.4 Platelet Function Monitoring Devices
14.8.5 Viscoelastic Coagulation Monitoring Devices
14.8.5.1 Rotational Thromboelastometry (Rotem)
14.8.5.2 Thromboelastography (Teg)
14.9 Drug-of-abuse (Doa) Testing Products
14.9.1 Doa Analysers
14.9.1.1 Immunoassays
14.9.1.2 Chromatographic Devices
14.9.1.3 Breath Analysers
14.9.2 Rapid Testing Devices
14.9.2.1 Urine Testing Devices
14.9.2.2 Oral Fluid Testing Devices
14.9.3 Others
14.10 Urinalysis Testing Products
14.10.1 Poc Urine Strip Self-testing
14.10.2 Poc Urine Test Strip Professional Testing
14.11 Cholesterol Testing Products
14.11.1 Testing Kits
14.11.2 Instruments
14.11.2.1 Table-top Analyzers
14.11.2.2 Hand-held Analyzers
14.12 Tumor/Cancer Marker Testing Products
14.13 Fecal Occult Testing Products
14.13.1 Guaiac Fob Stool Test
14.13.2 Lateral Flow Immuno-fob Test
14.13.3 Immuno-fob Agglutination Test
14.13.4 Immuno-fob Elisa Test
14.14 Others
15 Benelux Point-of-care Testing (Poct) Market, By Platform
15.1 Overview
15.2 Lateral Flow Assays/Immunochromatography Tests
15.3 Immunoassays
15.4 Dipsticks
15.5 Molecular Diagnostics
15.6 Clinical Chemistry Assays
15.7 Microfluidics
15.8 Hematology
15.9 Others
16 Benelux Point-of-care Testing (Poct) Market, By Prescription Mode
16.1 Overview
16.2 Otc Testing
16.3 Prescription-based Testing
17 Benelux Point-of-care-testing (Poct) Market, By Application
17.1 Overview
17.2 Blood Glucose
17.3 Infectious Diseases
17.3.1.1 Covid-19 Testing
17.3.1.2 Hiv Testing
17.3.1.3 Hepatitis C Testing
17.3.1.4 Influenza Testing
17.3.1.5 Tuberculosis Testing
17.3.1.6 Others
17.4 Vital Sign Monitoring
17.5 Cardiac Monitoring
17.6 Coagulation
17.7 Haematology
17.8 Non- Invasive Spo2 Monitoring
17.9 Blood Transfusion
17.10 Non- Invasive Pco2 Monitoring
17.11 Whole Blood Analysis
17.12 Others
18 Benelux Point-of-care Testing (Poct) Market, By End User
18.1 Overview
18.2 Hospitals
18.2.1 Private
18.2.1.1 Tier 1
18.2.1.2 Tier 2
18.2.1.3 Tier 3
18.2.2 Public
18.3 Home Care
18.4 Clinics
18.5 Laboratories
18.6 Diagnostic Centers
18.7 Pathology Labs
18.8 Ambulatory Surgery Centers
18.9 Elderly Care Centers
18.10 Others
19 Benelux Point-of-care-testing (Poct) Market, By Distribution Channel
19.1 Overview
19.2 Direct Tender
19.3 Retail Sales
19.4 Online Sales
19.5 Others
20 Gsa & Benelux
20.1 Germany
20.2 Netherlands
20.3 Switzerland
20.4 Belgium
20.5 Austria
20.6 Luxembourg
21 Gsa And Benelux Point-of-care-testing (Poct) Market: Company Landscape
21.1 Company Share Analysis: Gsa And Benelux
22 Swot Analysis
23 Company Profile
23.1 F. Hoffmann-la Roche Ltd
23.1.1 Company Snapshot
23.1.2 Revenue Analysis
23.1.3 Product Portfolio
23.1.4 Recent Development
23.2 Danaher Corporation
23.2.1 Company Snapshot
23.2.2 Revenue Analysis
23.2.3 Product Portfolio
23.2.4 Recent Development
23.3 Siemens Healthineers Ag
23.3.1 Company Snapshot
23.3.2 Revenue Analysis
23.3.3 Product Portfolio
23.3.4 Recent Development
23.4 Bio- Rad Laboratories, Inc.
23.4.1 Company Snapshot
23.4.2 Revenue Analysis
23.4.3 Product Portfolio
23.4.4 Recent Development
23.5 Biomerieux
23.5.1 Company Snapshot
23.5.2 Revenue Analysis
23.5.3 Product Portfolio
23.5.4 Recent Development
23.6 Accubiotech Co., Ltd.
23.6.1 Company Snapshot
23.6.2 Product Portfolio
23.6.3 Recent Development
23.7 Abbott
23.7.1 Company Snapshot
23.7.2 Revenue Analysis
23.7.3 Product Portfolio
23.7.4 Recent Development/News
23.8 Binx Health
23.8.1 Company Snapshot
23.8.2 Solution Portfolio
23.8.3 Recent Development
23.9 Bd
23.9.1 Company Snapshot
23.9.2 Revenue Analysis
23.9.3 Product Portfolio
23.9.4 Recent Development/News
23.10 Ekf Diagnostics Holdings Plc
23.10.1 Company Snapshot
23.10.2 Revenue Analysis
23.10.3 Product Portfolio
23.10.4 Recent Development
23.11 Hologic, Inc
23.11.1 Company Snapshot
23.11.2 Revenue Analysis
23.11.3 Product Portfolio
23.11.4 Recent Development
23.12 Meridian Bioscience, Inc.
23.12.1 Company Snapshot
23.12.2 Product Portfolio
23.12.3 Recent Development/News
23.13 Qiagen
23.13.1 Company Snapshot
23.13.2 Revenue Analysis
23.13.3 Product Portfolio
23.13.4 Recent Development
23.14 Quidelortho Corporation
23.14.1 Company Snapshot
23.14.2 Revenue Analysis
23.14.3 Product Portfolio
23.14.4 Recent Development
23.15 Sekisui Diagnostics
23.15.1 Company Snapshot
23.15.2 Product Portfolio
23.15.3 Recent Development
23.16 Sysmex Corporation
23.16.1 Company Snapshot
23.16.2 Revenue Analysis
23.16.3 Product Portfolio
23.16.4 Recent Development
23.17 Sienco, Inc.
23.17.1 Company Snapshot
23.17.2 Product Portfolio
23.17.3 Recent Development
23.18 Trinity Biotech
23.18.1 Company Snapshot
23.18.2 Revenue Analysis
23.18.3 Product Portfolio
23.18.4 Recent Development
23.19 Thermo Fisher Scientific Inc.
23.19.1 Company Snapshot
23.19.2 Revenue Analysis
23.19.3 Product Portfolio
23.19.4 Recent Development
23.20 Werfen
23.20.1 Company Snapshot
23.20.2 Product Portfolio
23.20.3 Recent Development
24 Questionnaire
List Of Tables
Table 1 Home-use Poct Devices With Telemedicine Integration
Table 2 Companies And Products With Telemedicine Integration
Table 3 A Technology Roadmap Outlining The Future Of Connected Poct Devices
Table 4 Gsa Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 5 Gsa Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 6 Gsa Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 7 Gsa Glucose Monitoring Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 8 Gsa Glucose Monitoring Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 9 Gsa Glucose Monitoring Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 10 Gsa Infectious Disease Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 11 Gsa Infectious Disease Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 12 Gsa Infectious Disease Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 13 Gsa Hiv Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 14 Gsa Hiv Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 15 Gsa Hiv Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 16 Gsa Sexually Transmitted Diseases (Std) Testing In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 17 Gsa Sexually Transmitted Diseases (Std) Testing In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 18 Gsa Sexually Transmitted Diseases (Std) Testing In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 19 Gsa Hepatitis C Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 20 Gsa Hepatitis C Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 21 Gsa Hepatitis C Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 22 Gsa Influenza Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 23 Gsa Traditional Diagnostic Test In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 24 Gsa Traditional Diagnostic Test In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 25 Gsa Traditional Diagnostic Test In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 26 Gsa Molecular Diagnostic Assay In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 27 Gsa Molecular Diagnostic Assay In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 28 Gsa Molecular Diagnostic Assay In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 29 Gsa Cardiometabolic Monitoring Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 30 Gsa Poc Analyzer In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 31 Gsa Poc Analyzer In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 32 Gsa Cardiac Marker Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 33 Gsa Cardiac Marker Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 34 Gsa Cardiac Marker Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 35 Gsa Blood Gas/Electrolyte Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 36 Gsa Blood Gas/Electrolyte Testing Consumables In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 37 Gsa Blood Gas/Electrolyte Testing Consumables In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 38 Gsa Blood Gas/Electrolyte Testing Consumables In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 39 Gsa Blood Gas/Electrolyte Testing Instruments In Point-of-care-testing (Poct) Market, By Type, 2018-2032 (Usd Thousand)
Table 40 Gsa Portable In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 41 Gsa Portable In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 42 Gsa Portable In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 43 Gsa Benchtop In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 44 Gsa Benchtop In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 45 Gsa Benchtop In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 46 Gsa Hba1c Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 47 Gsa Hba1c Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 48 Gsa Hba1c Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 49 Gsa Ecg Device In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 50 Gsa Ecg Device In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 51 Gsa Ecg Device In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 52 Gsa Pregnancy And Fertility Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 53 Gsa Pregnancy Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 54 Gsa Pregnancy Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 55 Gsa Pregnancy Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 56 Gsa Fertility Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 57 Gsa Fertility Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 58 Gsa Fertility Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 59 Gsa Coagulation Monitoring Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 60 Gsa Anticoagulation Monitoring Devices In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 61 Gsa Anticoagulation Monitoring Devices In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 62 Gsa Anticoagulation Monitoring Devices In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 63 Gsa Viscoelastic Coagulation Monitoring Devices In Point-of-care-testing (Poct) Market, By Method, 2018-2032 (Usd Thousand)
Table 64 Gsa Drug-of-abuse (Doa) Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 65 Gsa Doa Analyzers In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 66 Gsa Doa Analyzers In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Unit)
Table 67 Gsa Doa Analyzers Monitoring Devices In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 68 Gsa Rapid Testing Devices In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 69 Gsa Rapid Testing Devices In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 70 Gsa Rapid Testing Devices In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 71 Gsa Urinalysis Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 72 Gsa Urinalysis Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 73 Gsa Urinalysis Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 74 Gsa Cholesterol Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 75 Gsa Cholesterol Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 76 Gsa Cholesterol Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 77 Gsa Instruments In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 78 Gsa Instruments In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 79 Gsa Instruments In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 80 Gsa Fecal Occult Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 81 Gsa Fecal Occult Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 82 Gsa Fecal Occult Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 83 Gsa Point-of-care-testing (Poct) Market, By Prescription Mode, 2018-2032 (Usd Thousand)
Table 84 Gsa Point-of-care-testing (Poct) Market, By Platform, 2018-2032 (Usd Thousand)
Table 85 Gsa Point-of-care-testing (Poct) Market, By Application, 2018-2032 (Usd Thousand)
Table 86 Gsa Infectious Diseases In Point-of-care-testing (Poct) Market, By Type, 2018-2032 (Usd Thousand)
Table 87 Gsa Point-of-care-testing (Poct) Market, By End User, 2018-2032 (Usd Thousand)
Table 88 Gsa Hospitals In Point-of-care-testing (Poct) Market, By Type, 2018-2032 (Usd Thousand)
Table 89 Gsa Private In Point-of-care-testing (Poct) Market, By Level, 2018-2032 (Usd Thousand)
Table 90 Gsa Public In Point-of-care-testing (Poct) Market, By Level, 2018-2032 (Usd Thousand)
Table 91 Gsa Point-of-care-testing (Poct) Market, By Distribution Channel, 2018-2032 (Usd Thousand)
Table 92 Benelux Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 93 Benelux Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 94 Benelux Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 95 Benelux Glucose Monitoring Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 96 Benelux Glucose Monitoring Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 97 Benelux Glucose Monitoring Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 98 Benelux Infectious Disease Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 99 Benelux Infectious Disease Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 100 Benelux Infectious Disease Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 101 Benelux Hiv Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 102 Benelux Hiv Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 103 Benelux Hiv Testing Products In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Table 104 Benelux Sexually Transmitted Diseases (Std) Testing In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Usd Thousand)
Table 105 Benelux Sexually Transmitted Diseases (Std) Testing In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Volume In Thousand Units)
Table 106 Benelux Sexually Transmitted Diseases (Std) Testing In Point-of-care-testing (Poct) Market, By Product Type, 2018-2032 (Asp In Usd/Units)
Tab

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us